Poviztra FLXT 2.4mg 3ml Injection 1S
Rs. 8,549.05
Title
Poviztra FLXT 2.4mg 3ml Injection 1S
Prescription drug
Expiry
:
31-03-2028
About: Poviztra FLXT 2.4mg contains Semaglutide 2.4mg, the maintenance dose for chronic weight management in once-weekly injection.Usage Instructions: Inject subcutaneously once weekly on same day. Rotate injection sites. Titrate gradually from 0.25mg over 16-20 weeks to reach 2.4mg maintenance dose.Benefits: Maximum weight loss efficacy, substantial BMI reduction, improves metabolic parameters, cardiovascular risk reduction, once-weekly convenience.How it Works: Potent GLP-1 receptor activation, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, reducing appetite and caloric intake.Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, fatigue. Serious: pancreatitis, gallbladder disease, kidney injury, suicidal ideation.Safety Advice: Contraindicated in personal/family history of medullary thyroid carcinoma or MEN 2. Monitor for pancreatitis, gallbladder symptoms. Use caution in renal impairment. Not for pregnancy.Storage: Refrigerate at 2-8°C. Do not freeze. After first use, store below 30°C for up to 6 weeks. Protect from light. Keep pen cap on.
₹8,549.05
MRP: ₹8,999.00
Save ₹449.95
(5%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About: Poviztra FLXT 2.4mg contains Semaglutide 2.4mg, the maintenance dose for chronic weight management in once-weekly injection.Usage Instructions: Inject subcutaneously once weekly on same day. Rotate injection sites. Titrate gradually from 0.25mg over 16-20 weeks to reach 2.4mg maintenance dose.Benefits: Maximum weight loss efficacy, substantial BMI reduction, improves metabolic parameters, cardiovascular risk reduction, once-weekly convenience.How it Works: Potent GLP-1 receptor activation, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, reducing appetite and caloric intake.Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, fatigue. Serious: pancreatitis, gallbladder disease, kidney injury, suicidal ideation.Safety Advice: Contraindicated in personal/family history of medullary thyroid carcinoma or MEN 2. Monitor for pancreatitis, gallbladder symptoms. Use caution in renal impairment. Not for pregnancy.Storage: Refrigerate at 2-8°C. Do not freeze. After first use, store below 30°C for up to 6 weeks. Protect from light. Keep pen cap on.